EMCURE:NSE
Emcure Pharmaceuticals Ltd
၂,၃၃၇.၈၀ ₹
arrow_downward
-၀.၂၉%(-၆.၉၀) 1D
နို ၂၀, GMT+၅:၃၀ ၁၄:၅၀:၄၁ · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
၂,၃၅၇.၉၀ ₹
High
၂,၃၈၉.၀၀ ₹
Low
၂,၃၃၁.၀၀ ₹
Mkt. cap
ဋေ ၄.၄၄ သ
Avg. vol.
၂.၂၉ သိန်း
Volume
၆.၄၉ သောင်း
Dividend
၀.၁၅%
Quarterly dividend
၀.၉၀ ₹
Ex-dividend date
၂၀၂၆ စက် ၄
P/E ratio
၄၉.၀၇
52-wk high
၂,၄၂၉.၉၀ ₹
52-wk low
၁,၃၁၂.၃၀ ₹
EPS
၄၇.၆၄ ₹
No. of employees
၇ ထောင်
Open
၂,၃၅၇.၉၀ ₹
High
၂,၃၈၉.၀၀ ₹
Low
၂,၃၃၁.၀၀ ₹
Mkt. cap
ဋေ ၄.၄၄ သ
Avg. vol.
၂.၂၉ သိန်း
Volume
၆.၄၉ သောင်း
Dividend
၀.၁၅%
Quarterly dividend
၀.၉၀ ₹
Ex-dividend date
၂၀၂၆ စက် ၄
P/E ratio
၄၉.၀၇
52-wk high
၂,၄၂၉.၉၀ ₹
52-wk low
၁,၃၁၂.၃၀ ₹
EPS
၄၇.၆၄ ₹
No. of employees
၇ ထောင်
News stories
From web sources and news partners
MarketForces Africa
·
ပြီးခဲ့သည့် ၅၇ မိနစ်
S&P 500, Nasdaq, Dow Jones Dip Amidst Anthropic IPO Debut
Trefis
·
ပြီးခဲ့သည့် ၁ နာရီ
17 S&P 500 Stocks Hit 52-Week Lows On Thursday
BeInCrypto
·
ပြီးခဲ့သည့် ၂၁ မိနစ်
S&P 500 Logs Its Longest Losing Streak Since 2024. Here’s What Happened Last Time
Investing.com
·
ပြီးခဲ့သည့် ၁ နာရီ
S&P 500 Breaks Support as Global Risk Sentiment Begins to Crack
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees၆.၉၁ ထောင်
Founded၁၉၈၁ ဧ ၁၆
Headquarters-
SectorHealth Care
Industry-
Websiteemcure.com